ClinicalTrials.govpublic full text
Study to Evaluate Changes in Cognitive Function in Patients Treated With PCSK9 Inhibitors
cognitive function, hypercholesterolemia, quality of life, pharmacoeconomics, pcsk9 inhibitors, alirocumab, evolocumab, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 837275
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.